Ss Innovations International

SS Innovations makes robotic systems that help doctors perform complex surgeries. These tools make advanced healthcare more affordable for hospitals and patients. The company focuses on bringing high-tech surgery to underserved regions.

What's in the Robotic Toolkit?

• SSi Mantra: Modular robotic surgery system used for over 100 different types of surgical procedures including cardiac and urology.
• SSi Mudra: Collection of more than 40 surgical instruments such as forceps and scissors used for precise cutting and suturing.
• SSi Maya: Digital health platform that combines artificial intelligence and mixed reality for surgeon training and patient education.
• Digital Visualization: High-definition 3D viewing systems and headsets that provide surgeons with ten times magnification of the surgical area.

Expanding the Global Footprint

• Completed a private placement on March 6, 2026, raising over $18.6 million for working capital and international expansion.
• Submitted a 510(k) notification to the U.S. Food and Drug Administration in December 2025 to seek clearance for American markets.
• Introduced the SSi Mantra 3 in India during November 2024 featuring new telesurgery and tele-proctoring capabilities.
• Performed the first inter-continental robotic cardiac telesurgery from **France** to **India** in July 2025.

Cutting-Edge Precision

The company utilizes a modular design with individual robotic arm carts that can be positioned flexibly for different surgical needs. Its proprietary software translates a surgeon's hand movements into precise instrument actions while filtering out tremors and scaling movements for delicate tasks.

Checking the Vital Signs

• Revenue reached $14.5 million in Q4 2025, up 158.3% from $5.6 million in Q4 2024.
• Gross profit rose to $6.1 million in Q4 2025, up 99.8% year-over-year.
• Operating loss narrowed to $697,969 in Q4 2025, an improvement of 90.9% from the previous year.
• Net loss improved by 66.8% to reach $2.5 million in Q4 2025 compared to $7.5 million in Q4 2024.

The Path Forward

SS Innovations has evolved from a development-stage firm into a commercial manufacturer with 168 systems installed across 10 countries as of late 2025. Its focus on modularity and remote surgery capabilities supports a long-term goal of making robotic healthcare accessible to a global population.